{"version":"1.0","provider_name":"Neuraxpharm France","provider_url":"https:\/\/www.neuraxpharm.com\/fr","author_name":"Jaime Fern\u00e1ndez","author_url":"https:\/\/www.neuraxpharm.com\/fr\/blog\/auteur\/jaime","title":"MIGUEL BARRERO","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"Gt4lHzVour\"><a href=\"https:\/\/www.neuraxpharm.com\/fr\/a-propos-de-nous\/comite-executif\/miguel-barrero\">MIGUEL BARRERO<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.neuraxpharm.com\/fr\/a-propos-de-nous\/comite-executif\/miguel-barrero\/embed#?secret=Gt4lHzVour\" width=\"600\" height=\"338\" title=\"\u00ab\u00a0MIGUEL BARRERO\u00a0\u00bb &#8212; Neuraxpharm France\" data-secret=\"Gt4lHzVour\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.neuraxpharm.com\/fr\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","description":"https:\/\/www.linkedin.com\/in\/mbarrero\/ Neuraxpharm Miguel Barrero Miguel Barrero Dur\u00e1n est Directeur du d\u00e9veloppement commercial et de i\u2019Innovation et a rejoint Neuraxpharm en 2015, o\u00f9 il a cr\u00e9\u00e9 et d\u00e9velopp\u00e9 les d\u00e9partements du d\u00e9veloppement commercial et des licences, de la gestion des alliances et du pipeline de produits. Miguel dirige \u00e9galement les d\u00e9partements de propri\u00e9t\u00e9 intellectuelle et de [&hellip;]","thumbnail_url":"https:\/\/www.neuraxpharm.com\/fr\/wp-content\/uploads\/sites\/15\/2023\/03\/m-barrero.jpg"}